Dihydropyridines (DHPs) are a class of organic molecules which regulate voltage-dependent calcium channels in a variety of tissues. In skeletal muscle the DHP binding proteins (DHPBP) play an important role in DHPBP and its individual subunits to help to define the role of this oligomeric protein in E-C coupling. The DHPBP of rabbit skeletal muscle is a oligomeric protein with a 170K (alpha 1), a 140K (alpha 2), a 52K (beta), a 35K (gamma), and a 30K (delta) subunit. A small fraction of the alpha 1 subunit also exists as a non-proteolyzed 212K polypeptide. Definition of the arrangement of these subunits in the membrane and mapping of the location of physiologically significant drug binding sites on the subunits will greatly advance our understanding of how this protein functions as both an ion channel and a voltage sensor. We propose to prepare monoclonal antibodies to peptides and to subunits to use to: 1) establish the topology of the individual subunits with respect to the membrane by a combination of epitope mapping and electron microscopy, 2) determine the relative locations of the subunits with respect one another by analyzing the composition of partially dissociated and/or reconstituted complexes, 3) purify individual subunits of the DHPBP, and 4) probe for effects on dihydropyridine binding and on calcium channel activity. We also propose to determine the location of pharmacologically important binding sites, and the disulfide bond between alpha 2, and delta by peptide mapping and N-terminal amino acid sequencing.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL037044-08
Application #
3780587
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
8
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Kiehn, J; Lacerda, A E; Brown, A M (1999) Pathways of HERG inactivation. Am J Physiol 277:H199-210
Accili, E A; Kuryshev, Y A; Wible, B A et al. (1998) Separable effects of human Kvbeta1.2 N- and C-termini on inactivation and expression of human Kv1.4. J Physiol 512 ( Pt 2):325-36
Suh-Kim, H; Wei, X; Birnbaumer, L (1996) Subunit composition is a major determinant in high affinity binding of a Ca2+ channel blocker. Mol Pharmacol 50:1330-7
Kiehn, J; Wible, B; Lacerda, A E et al. (1996) Mapping the block of a cloned human inward rectifier potassium channel by dofetilide. Mol Pharmacol 50:380-7
Dumaine, R; Wang, Q; Keating, M T et al. (1996) Multiple mechanisms of Na+ channel--linked long-QT syndrome. Circ Res 78:916-24
Jarolimek, W; Soman, K V; Alam, M et al. (1996) Structure-activity relationship of quaternary ammonium ions at the external tetraethylammonium binding site of cloned potassium channels. Mol Pharmacol 49:165-71
Pascual, J M; Shieh, C C; Kirsch, G E et al. (1995) K+ pore structure revealed by reporter cysteines at inner and outer surfaces. Neuron 14:1055-63
Crumb Jr, W J; Wible, B; Arnold, D J et al. (1995) Blockade of multiple human cardiac potassium currents by the antihistamine terfenadine: possible mechanism for terfenadine-associated cardiotoxicity. Mol Pharmacol 47:181-90
el-Hayek, R; Antoniu, B; Wang, J et al. (1995) Identification of calcium release-triggering and blocking regions of the II-III loop of the skeletal muscle dihydropyridine receptor. J Biol Chem 270:22116-8
Parent, L; Gopalakrishnan, M (1995) Glutamate substitution in repeat IV alters divalent and monovalent cation permeation in the heart Ca2+ channel. Biophys J 69:1801-13

Showing the most recent 10 out of 131 publications